Cognitive Behavioral Therapy: Clinical Trials

130 trials of Cognitive Behavioral Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

99 completed, 11 unknown, 7 recruiting, 4 active not recruiting. 130 Phase 2, 25 Phase 1, 20 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2130Completed 99, Unknown 11, Recruiting 7, Active not recruiting 4, Terminated 4, Not yet recruiting 3, Withdrawn 2
Phase 125Completed 20, Not yet recruiting 2, Recruiting 1, Terminated 1, Unknown 1
Phase 320Completed 16, Unknown 2, Active not recruiting 1, Not yet recruiting 1

Follow Cognitive Behavioral Therapy: new trials by email Literature Review of Cognitive Behavioral Therapy trials Research Report on Cognitive Behavioral Therapy

Trials (filtered) newest first · largest first

All 130 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients
Naltrexone hydrochloride, Bupropion Hydrochloride Extended-release, Cognitive-Behavioral Therapy - Obesity, Smoking Cessation
Phase 1 / Phase 2Not yet recruitingMedical University of South Carolina642026-09-012026-07-08
Tiaoshen Anti-cancer Protocol and CBT for Insomnia and Survival in Ovarian Cancer
Tiaoshen Anti-cancer Granules, Placebo Granules, Cognitive Behavioral Therapy for Insomnia - Ovarian Neoplasms Malignant, Sleep Initiation and Maintenance Disorders
Phase 2 / Phase 3Not yet recruitingShanghai Municipal Hospital of Traditional Chinese Medicine3602026-05-012026-04-24
Repurposing Semaglutide for the Treatment of Cocaine Use Disorder
Semaglutide, Placebo, cognitive behavioral therapy (CBT). - Cocaine Use Disorder
Phase 2RecruitingThe University of Texas Health Science Center, Houston752026-01-152026-03-19
RCT of Psilocybin-assisted CBT for Depression
Psilocybin (drug), cognitive behavioral therapy, Minimal supportive therapy - Major Depressive Diorder
Phase 1 / Phase 2RecruitingUniversity of California, Los Angeles502026-01-052026-02-12
Resilience Enhancement Following Sleep Treatment
Cognitive-behavioral therapy for insomnia (CBTi), CBTi + Savoring Meditation, CBTi + Pain Education - Chronic Low Back Pain (CLBP), Insomnia
Phase 2RecruitingUniversity of Virginia3002025-12-162025-12-23
Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)
Ketamine, Cognitive Behavioural Therapy - Alcohol Use Disorder (AUD), Major Depressive Disorder (MDD)
Phase 1 / Phase 2Not yet recruitingSouth West Sydney Local Health District202025-12-102025-11-25
MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)
3,4-Methyl enedioxy methamphetamine, Methamphetamine, Cognitive Behavioral Therapy (CBT) - Obsessive-Compulsive Disorder
Phase 2RecruitingCarolyn Rodriguez402025-09-102026-03-05
Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers
Psilocybin, Cognitive Behavioral Therapy (CBT) - Major Depressive Disorder
Phase 2CompletedKhyber Medical University Peshawar602024-12-012025-09-02
Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis
Cognitive behavioral therapy for insomnia, Sleep and lifestyle education - Multiple Sclerosis, Insomnia
Phase 2Active not recruitingUniversity of Kansas Medical Center702024-07-302026-10-08
CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
Cognitive Behavioral Therapy for Insomnia - Primary Brain Tumor, Glioblastoma
Phase 2CompletedVirginia Commonwealth University702024-07-082025-10-01
Neuroimaging Correlates and Feasibility of Transcranial Magnetic Stimulation (TMS) to Improve Smoking Cessation Outcomes in Veterans With Comorbid PTSD
active repetitive transcranial magnetic stimulation, sham repetitive transcranial magnetic stimulation, cognitive behavioral therapy for smoking cessation - Tobacco Use Disorder
Phase 2RecruitingVA Office of Research and Development502023-10-312026-02-18
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
Melatonin, Placebo for Melatonin, Methylphenidate - Sleep, Fatigue
Phase 2 / Phase 3Active not recruitingM.D. Anderson Cancer Center1692022-11-212026-09-25
Enhanced CBTi for Older Adult Sleep and Cognition
CBTi with Application, CBTi, Sleep Hygiene Education - Insomnia, Alzheimers Disease Related Dementias
Phase 2 / Phase 3CompletedPenn State University602022-03-162024-04-12
Treatment Interrupts Depression Early
Cognitive-Behavioural Therapy, Antidepressant medication - Depression
Phase 2RecruitingNova Scotia Health Authority1002021-12-022025-05-14
Heart Rate Variability Biofeedback for Smoking Cessation Treatment
Cognitive-Behavioral Smoking Cessation, Heart Rate Variability Biofeedback, Nicotine patch - Tobacco Smoking
Phase 2CompletedRutgers, The State University of New Jersey282021-11-292024-05-01
Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention
Cognitive Behavioral Therapy (CBT), Pioglitazone, Placebo - Cocaine Use Disorder
Phase 2CompletedThe University of Texas Health Science Center, Houston612021-08-232026-09-21
Vivitrol Treatment for Cannabis Use Disorder
Naltrexone 380 MG [Vivitrol], Motivational Enhancement Therapy and Cognitive Behavioral Therapy - Cannabis Use Disorder
Phase 2TerminatedCentre for Addiction and Mental Health12021-06-092025-02-07
eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk
Good Days Ahead (GDA), Problem Solving Treatment in Primary Care (PST-PC), Antidepressant Medications - Depression, Major Depressive Disorder
Phase 2CompletedIndiana University462020-10-142023-11-02
Heart Rate Variability Biofeedback for Smoking Cessation
Cognitive-Behavioral Smoking Cessation, Heart Rate Variability Biofeedback (HRVB), Transdermal Nicotine patch - Tobacco Smoking
Phase 2CompletedRutgers, The State University of New Jersey102019-04-242020-08-25
Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue
Cognitive Behavior Therapy, Quality-of-Life Assessment, Questionnaire Administration - Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Phase 2Active not recruitingM.D. Anderson Cancer Center482018-11-292026-05-20

Showing 20 of 130. Sign in to see all of them.

Conditions studied

Depression (24)  ·  Anxiety Disorders (14)  ·  Sleep Initiation and Maintenance Disorders (12)  ·  Stress Disorders, Post-Traumatic (10)  ·  Substance-Related Disorders (10)  ·  Depressive Disorder, Major (9)  ·  Cocaine-Related Disorders (8)  ·  Smoking Cessation (8)  ·  Alcoholism (7)  ·  Obsessive-Compulsive Disorder (6)  ·  Generalized Anxiety Disorder (5)  ·  Obesity (5)  ·  Panic Disorder (5)  ·  Phobia, Social (5)  ·  Anxiety, Separation (4)

Sponsors

University of Pennsylvania (6)  ·  Medical University of South Carolina (5)  ·  University of South Florida (5)  ·  Centre for Addiction and Mental Health (4)  ·  Duke University (4)  ·  The University of Texas Health Science Center, Houston (4)  ·  University of California, Los Angeles (4)  ·  M.D. Anderson Cancer Center (3)  ·  Massachusetts General Hospital (3)  ·  VA Office of Research and Development (3)  ·  Yale University (3)  ·  Dartmouth-Hitchcock Medical Center (2)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2)  ·  Indiana University (2)  ·  Kaiser Permanente (2)

Countries

United States (90)  ·  Canada (10)  ·  Norway (6)  ·  Australia (4)  ·  China (2)  ·  Netherlands (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Denmark (1)  ·  Germany (1)  ·  Pakistan (1)  ·  Puerto Rico (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Eric Storch, Ph.D. (3)  ·  Joy M Schmitz, PhD (3)  ·  Denise E Wilfley, Ph.D. (2)  ·  Mark P. McGovern, Ph.D. (2)  ·  Michael S Scheeringa, MD, MPH (2)  ·  Aaron T Beck, MD (1)  ·  Aleksandra Zgierska, MD PhD (1)  ·  Alexander L. Gerlach, Prof. Dr. (1)  ·  Alfons O. Hamm, Prof. Dr. (1)  ·  Alice Rose (1)  ·  Allan S Kaplan, MD (1)  ·  Allen Thornton (1)  ·  Allison G Harvey, PhD (1)  ·  Anders Hovland, PsyD (1)  ·  Andrew Krystal, M.D. (1)

Results publications

PMID 12150647, PMID 24506079, PMID 28569390, PMID 12233992, PMID 12957348, PMID 18314433, PMID 18348595, PMID 18457236, PMID 19182688, PMID 19223438, PMID 19309326, PMID 19485586, PMID 19695776, PMID 19730273, PMID 19730274, PMID 19786427, PMID 19814948, PMID 19858762, PMID 19968380, PMID 20008943, PMID 20093899, PMID 20211945, PMID 20478877, PMID 20570701, PMID 20817153, PMID 21192150, PMID 21208583, PMID 21334569, PMID 21383263, PMID 21456040, PMID 21515198, PMID 21565525, PMID 21656058, PMID 21784297, PMID 21785892, PMID 21969420, PMID 22024002, PMID 22233247, PMID 22251024, PMID 22282429, PMID 22284022, PMID 22394471, PMID 22449646, PMID 22511033, PMID 22539780, PMID 22659077, PMID 22943030, PMID 23108976, PMID 23257654, PMID 23277304

NIH funding

K23DA016574 (2), R34DA043751 (2), 1RC1MH088969-01 (1), K08MH001662 (1), K23DA064898 (1), K23MH001831 (1), K23MH069754 (1), P30CA016672 (1), P50DA009262 (1), P50DA018197 (1), R01AA013964 (1), R01AA025086 (1), R01AR047219 (1), R01AR052368 (1), R01AT010171 (1)